Silis Labs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 06-07-2024
- Paid Up Capital ₹ 0.20 M
as on 06-07-2024
- Company Age 15 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 33.83%
(FY 2022)
- Profit 8.74%
(FY 2022)
- Ebitda 5.93%
(FY 2022)
- Net Worth 73.96%
(FY 2022)
- Total Assets 22.06%
(FY 2022)
About Silis Labs
The Company is engaged in the Professional Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Divya Maheshwari, Rahul Maheshwari, Martin Igbonacho, and One other member serve as directors at the Company.
- CIN/LLPIN
U73100GJ2009PTC057673
- Company No.
057673
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jul 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Silis Labs?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Maheshwari  | Director | 30-Jul-2009 | Current |
| Divya Maheshwari | Director | 30-Jul-2009 | Current |
Martin Igbonacho  | Director | 05-Apr-2011 | Current |
| Stephen Okoronkwo | Director | 05-Apr-2011 | Current |
Financial Performance and Corporate Structure Insights of Silis Labs.
Silis Labs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 33.83% increase. The company also saw a slight improvement in profitability, with a 8.74% increase in profit. The company's net worth Soared by an impressive increase of 73.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Silis Labs?
Unlock access to Silis Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Defi Healthcare Private Limited
Active 21 years 14 daysDivya Maheshwari and Rahul Maheshwari are mutual person
Aarya Lifesciences Private Limited
Active 20 years 9 monthsDivya Maheshwari and Rahul Maheshwari are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Silis Labs?
Unlock and access historical data on people associated with Silis Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Silis Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Silis Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
